These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30374140)

  • 1. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes.
    Soler A; Cayrefourcq L; Mazard T; Babayan A; Lamy PJ; Assou S; Assenat E; Pantel K; Alix-Panabières C
    Sci Rep; 2018 Oct; 8(1):15931. PubMed ID: 30374140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a cell line from human circulating colon cancer cells.
    Cayrefourcq L; Mazard T; Joosse S; Solassol J; Ramos J; Assenat E; Schumacher U; Costes V; Maudelonde T; Pantel K; Alix-Panabières C
    Cancer Res; 2015 Mar; 75(5):892-901. PubMed ID: 25592149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
    Cayrefourcq L; Thomas F; Mazard T; Assenat E; Assou S; Alix-Panabières C
    Mol Cancer; 2021 Feb; 20(1):30. PubMed ID: 33557844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.
    Dago AE; Stepansky A; Carlsson A; Luttgen M; Kendall J; Baslan T; Kolatkar A; Wigler M; Bethel K; Gross ME; Hicks J; Kuhn P
    PLoS One; 2014; 9(8):e101777. PubMed ID: 25084170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
    Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
    Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
    Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
    Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
    Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
    Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Studies on Viable Circulating Tumor Cells.
    Pantel K; Alix-Panabières C
    Clin Chem; 2016 Feb; 62(2):328-34. PubMed ID: 26637479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC).
    Messaritakis I; Stoltidis D; Kotsakis A; Dermitzaki EK; Koinis F; Lagoudaki E; Koutsopoulos A; Politaki E; Apostolaki S; Souglakos J; Georgoulias V
    Sci Rep; 2017 Mar; 7():45351. PubMed ID: 28349943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
    Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
    PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in
    Grillet F; Bayet E; Villeronce O; Zappia L; Lagerqvist EL; Lunke S; Charafe-Jauffret E; Pham K; Molck C; Rolland N; Bourgaux JF; Prudhomme M; Philippe C; Bravo S; Boyer JC; Canterel-Thouennon L; Taylor GR; Hsu A; Pascussi JM; Hollande F; Pannequin J
    Gut; 2017 Oct; 66(10):1802-1810. PubMed ID: 27456153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous phenotypic and genetic characterization of single circulating tumor cells from colon cancer patients.
    Campos M; Luque R; Jiménez J; Martínez R; Warleta F; Sánchez-Quesada C; Delgado-Rodríguez M; Calvo A; Gaforio JJ
    Histol Histopathol; 2013 Nov; 28(11):1439-50. PubMed ID: 23653253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.
    Alix-Panabières C; Cayrefourcq L; Mazard T; Maudelonde T; Assenat E; Assou S
    Clin Chem; 2017 Mar; 63(3):700-713. PubMed ID: 28007957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.